{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T17:25:13Z","timestamp":1780593913783,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.transproceed.2024.05.015","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T04:01:05Z","timestamp":1718337665000},"page":"1169-1172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of Hyperlipidemia With Alirocumab in a Liver Transplant Recipient With Poor Blood Lipid Control: Case Report"],"prefix":"10.1016","volume":"56","author":[{"given":"Tie-Yan","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2024.05.015_bib0001","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.jceh.2022.03.012","article-title":"Long-term care of the adult liver transplant recipient","volume":"12","author":"Neuberger","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0002","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/liv.13308","article-title":"Hepatotoxicity of statins and other lipid-lowering agents","volume":"37","author":"Bj\u00f6rnsson","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0003","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0004","first-page":"1057","article-title":"Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity","volume":"60","author":"Stegall","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0005","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/lt.500030409","article-title":"Hyperlipidemia in liver transplant recipients: prevalence and risk factors","volume":"3","author":"Gisbert","year":"1997","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0006","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/lt.21126","article-title":"Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events","volume":"13","author":"Laryea","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0007","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1097\/TP.0000000000001693","article-title":"mTOR Inhibition and cardiovascular diseases: dyslipidemia and atherosclerosis","volume":"102(2S Suppl 1)","author":"Kurdi","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0008","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/s41598-020-79673-5","article-title":"An observational study on the effect of hypercholesterolemia developed after living donor liver transplantation on cardiac event and graft failure","volume":"11","author":"Park","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0009","doi-asserted-by":"crossref","first-page":"53E","DOI":"10.1016\/j.amjcard.2005.06.006","article-title":"Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options","volume":"96","author":"Stone","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0010","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S2468-1253(19)30181-5","article-title":"Management of metabolic syndrome and cardiovascular risk after liver transplantation","volume":"4","author":"Fatourou","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0011","first-page":"183","article-title":"Metabolic and cardiovascular complications in the liver transplant recipient","volume":"28","author":"Luca","year":"2015","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0012","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/apt.17192","article-title":"Use of statins after liver transplantation is associated with improved survival: results of a nationwide study","volume":"56","author":"Becchetti","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0013","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurheartj\/eht055","article-title":"HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin\/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment","volume":"34","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0014","first-page":"833","article-title":"Joint committee issued Chinese guideline for the management of dyslipidemia in adults. [2016 Chinese guideline for the management of dyslipidemia in adults]","volume":"44","year":"2016","journal-title":"Chin J Cardiol"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0015","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/138920008784220664","article-title":"Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4","volume":"9","author":"Zhou","year":"2008","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0016","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jacl.2019.01.011","article-title":"Management of dyslipidemia in adult solid organ transplant recipients","volume":"13","author":"Warden","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0017","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2146\/ajhp120131","article-title":"Fenofibrate-associated nephrotoxicity: a review of current evidence","volume":"70","author":"Attridge","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0018","doi-asserted-by":"crossref","first-page":"111","DOI":"10.12659\/AOT.883229","article-title":"Tacrolimus-induced nephrotoxicity and genetic variability: a review","volume":"17","author":"Gijsen","year":"2012","journal-title":"Ann Transplant"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0019","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.jacc.2019.08.010","article-title":"Evolocumab for early reduction of LDL cholesterol levels in patients with acute coronary syndromes (EVOPACS)","volume":"74","author":"Koskinas","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamacardio.2020.3151","article-title":"Efficacy and safety of PCSK9 inhibition with evolocumab in reducing cardiovascular events in patients with metabolic syndrome receiving statin therapy: secondary analysis from the FOURIER randomized clinical trial","volume":"6","author":"Deedwania","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0021","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/ehjcvp\/pvad019","article-title":"The efficacy of PCSK9 inhibitors on major cardiovascular events and lipid profile in patients with diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"Imbalzano","year":"2023","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0022","first-page":"1141","article-title":"[The triglyceride-lowering effects of PCSK9 inhibitor differ in patients with different baseline triglyceride levels]","volume":"40","author":"Peng","year":"2020","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0023","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40292-019-00323-7","article-title":"Low-density lipoprotein (LDL) cholesterol as a causal role for atherosclerotic disease: potential role of PCSK9 inhibitors","volume":"26","author":"Del Pinto","year":"2019","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0024","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006910","article-title":"Effect of PCSK9 inhibitors on clinical outcomes in patients with hypercholesterolemia: a meta-analysis of 35 randomized controlled trials","volume":"6","author":"Karatasakis","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0025","article-title":"PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis","volume":"377","author":"Khan","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0026","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10741-022-10255-5","article-title":"PCSK9 inhibitors safely and effectively lower LDL after heart transplantation: a systematic review and meta-analysis","volume":"28","author":"Jennings","year":"2023","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0027","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.recesp.2019.05.014","article-title":"Treatment of hypercholesterolemia with PCSK9 inhibitors in heart transplant recipients. first experience in Spain","volume":"72","author":"Groba-Marco","year":"2019","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210373","article-title":"Treatment of hypercholesterolaemia with PCSK9 inhibitors in patients after cardiac transplantation","volume":"14","author":"Kuhl","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.transproceed.2024.05.015_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.cjca.2018.11.004","article-title":"Safety and efficacy of PCSK9 inhibitors after heart transplantation","volume":"35","author":"Moayedi","year":"2019","journal-title":"Can J Cardiol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524002835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524002835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T12:28:23Z","timestamp":1723033703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134524002835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0041134524002835"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.05.015","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Hyperlipidemia With Alirocumab in a Liver Transplant Recipient With Poor Blood Lipid Control: Case Report","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}